Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank Mccormick currently holds 5,277 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Mccormick has been a net seller of BBIO stock. They have purchased $0 and sold $29.5M worth of shares.
Frank Mccormick's most recent insider trade was on Jun 22, 2026, when they sold 5,277 shares at $0.00 per share.
Frank Mccormick serves as Executive at BridgeBio Pharma, Inc. (BBIO). They have executed 35 insider transactions totaling $29.5M over their tenure at the company.
Frank Mccormick holds the position of Executive at BridgeBio Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Frank Mccormick has shown a selling trading pattern, with $0 in total purchases and $29.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Frank Mccormick was on Oct 29, 2025, when they sold $7.3M worth of BBIO shares. This transaction involved 111,755 shares at $65.48 per share.
Frank Mccormick currently owns 5,277 shares of BridgeBio Pharma, Inc. (BBIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank Mccormick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank Mccormick has 35 Form 4 filings on record as an insider at BridgeBio Pharma, Inc..
Set alerts for Frank Mccormick and 40,000+ other insiders.